Skip to content
Sign in

SGRY · NASDAQ

Surgery Partners (SGRY) Stock Price & Fundamentals

$900.99−0.98%−$8.95End-of-day price as of Oct 9, 2026

Surgery Partners (SGRY) closed at $900.99 on Oct 9, 2026, down 0.98% from the previous close of $909.94.

Share price, past year

1Y +19.85%

52-week range $740.73 – $990.21. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$900.99
Sep 30, 2026$920.35
Aug 31, 2026$906.78
Jul 31, 2026$960.03
Jun 30, 2026$943.79
May 29, 2026$899.91
Apr 30, 2026$901.85
Mar 31, 2026$911.02
Feb 27, 2026$866.31
Jan 30, 2026$800.65
Dec 31, 2025$784.46
Nov 28, 2025$803.75
Oct 31, 2025$784.56

Key statistics

Market cap
$117.93B
P/E (TTM)
—
EPS (TTM)
−$0.69
Revenue (TTM)
$3.37B
Net income (TTM)
−$88.60M
Shares outstanding
130.9M
Dividend yield
—
52-week range
$740.73 – $990.21

Surgery Partners's market cap is $117.93B, based on a share price of $900.99 and 130.9M shares outstanding as of Jun 30, 2026.

Financials

Surgery Partners reported revenue of $3.31B for fiscal 2025, up 6.24% from fiscal 2024.

Surgery Partners reported a net loss of $77.90M in fiscal 2025.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY15FY16FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Surgery Partners annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$3.31B+6.2%−$77.90M−2.4%−$0.61$195.60M
FY2024ended Dec 31, 2024$3.11B+13.5%−$168.10M−5.4%−$1.33$209.70M
FY2023ended Dec 31, 2023$2.74B+8.0%−$11.90M−0.4%−$0.09$205.00M
FY2022ended Dec 31, 2022$2.54B+14.1%−$54.60M−2.2%−$0.59$78.20M
FY2021ended Dec 31, 2021$2.23B+19.6%−$70.90M−3.2%−$1.12$29.50M
FY2020ended Dec 31, 2020$1.86B+1.6%−$116.10M−6.2%−$3.19$204.00M
FY2019ended Dec 31, 2019$1.83B+3.4%−$74.80M−4.1%−$2.29$55.90M
FY2018ended Dec 31, 2018$1.77B+54.7%−$205.70M−11.6%−$4.96$104.80M
FY2016ended Dec 31, 2016$1.15B+19.3%$9.45M0.8%$0.20$86.13M
FY2015ended Dec 31, 2015$959.89M—$1.43M0.2%$0.04$51.04M
Surgery Partners quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$848.90M−$15.00M−$0.12
Q1 FY2026ended Mar 31, 2026$810.90M−$35.90M−$0.28
Q4 FY2025ended Dec 31, 2025$885.00M−$15.00M−$0.11
Q3 FY2025ended Sep 30, 2025$821.50M−$22.70M−$0.18
Q2 FY2025ended Jun 30, 2025$826.20M−$2.50M−$0.02
Q1 FY2025ended Mar 31, 2025$776.00M−$37.70M−$0.30
Q4 FY2024ended Dec 31, 2024$864.40M−$108.50M−$0.86
Q3 FY2024ended Sep 30, 2024$770.40M−$31.70M−$0.25

Company profile

Name
Surgery Partners, Inc.
Ticker
SGRY
Exchange
NASDAQ
Industry (SEC SIC)
Services-General Medical & Surgical Hospitals, NEC
Headquarters
340 Seven Springs Way, Suite 600, Brentwood, TN
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001638833

Recent SEC filings

Frequently asked questions

What is Surgery Partners's stock price?

Surgery Partners (SGRY) closed at $900.99 on Oct 9, 2026, down 0.98% from the previous close of $909.94.

What is Surgery Partners's market cap?

Surgery Partners's market cap is $117.93B, based on a share price of $900.99 and 130.9M shares outstanding as of Jun 30, 2026.

How much revenue does Surgery Partners make?

Surgery Partners reported revenue of $3.31B for fiscal 2025, up 6.24% from fiscal 2024.

Does Surgery Partners pay a dividend?

Surgery Partners's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Surgery Partners, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures